Utama › Kegagalan Jantung › Oklahoma
Kajian klinikal Kegagalan Jantung di Oklahoma
17 kajian untuk Kegagalan Jantung sedang mencari peserta di lokasi di Oklahoma.
Bandar di Oklahoma
Teks kajian rasmi (Bahasa Inggeris)
Early Feasibility Study - Edwards APTURE Transcatheter Shunt System
- Oklahoma Heart Institute, Tulsa
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT03523416A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Oklahoma Heart Institute, Tulsa
Mengambil peserta
Umur 18 hingga 85 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07214376A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Oklahoma City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Oklahoma State University Center for Health Sciences, Tulsa
Mengambil pesertaFasa 3
Umur 18 hingga 85 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06736574Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- South Oklahoma Heart Research, Oklahoma City
Mengambil pesertaFasa 3
Umur 18 hingga 99 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Oklahoma City
- Research Site, Oklahoma City
Mengambil pesertaFasa 3
Umur 40 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Bartlesville, OK Investigative Site 10095, Bartlesville
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06008197Pedal Pump Clinical Trial on Edema V2
- Hillcrest Medical Center, Tulsa
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07809516NORM-HF Pivotal Study
- Saint Francis Health System, Tulsa
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT07574593Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
- Oklahoma Cardiovascular Research Group, Oklahoma City
Mengambil peserta
Umur 21 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT05677100Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Oklahoma City
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT00271180Alleviant ALLAY-HF Study
- South Oklahoma Heart Research, LLC., Oklahoma City
Mengambil peserta
Umur 40 ke atas · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT05685303Pedal Pump Clinical Trial on Edema V1
- Hillcrest Medical Center, Tulsa
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT07760363Assessment of CCM in HF With Higher Ejection Fraction
- Oklahoma Heart Institute, Tulsa
- St. Francis Hospital - Tulsa, Tulsa
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT05064709Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
- Saint Francis Hospital, Tulsa
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jul 2026 · NCT06552637Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Integris Baptist Medical Center, Oklahoma City
- Oklahoma Heart Institute at Utica, Tulsa
- Saint Francis Hospital, Tulsa
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jun 2026 · NCT06526195The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Oklahoma Heart Institute Hospital, Tulsa
- Saint Francis Hospital,, Tulsa
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Apr 2026 · NCT03142152Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.